11/02/2026
https://www.facebook.com/share/1FCyx5vt8d/?mibextid=wwXIfr
Ohh red light therapy - photodynamic therapy to kill HPV virus
In early 2026, Mexican researcher Dr. Eva Ramón Gallegos has garnered renewed global attention for her work in non-invasive oncology, specifically her research into the total eradication of the Human Papilloma Virus (HPV). Utilizing a specialized method known as photodynamic therapy (PDT), Gallegos and her team at the National Polytechnic Institute (IPN) have demonstrated the ability to eliminate the virus in a clinical setting. This breakthrough is particularly significant for Mexico, where cervical cancer—often triggered by persistent HPV infection—remains a leading cause of death among women.
The treatment involves the application of a photosensitizing agent, delta-aminolevulinic acid, to the cervix, which is later activated by a specific wavelength of red laser light. This targeted reaction produces a reactive form of oxygen that selectively destroys virus-infected cells while leaving healthy surrounding tissue intact. In controlled studies involving women from Mexico City, the researchers observed a 100% clearance rate of the virus in patients who did not yet have premalignant lesions. This efficacy offers a promising, fertility-preserving alternative to more invasive procedures like cryotherapy or surgical excision.
While these results are a major milestone in the search for an HPV cure, experts emphasize that the findings are based on small-scale, controlled clinical groups and have not yet been transitioned to the general population. For this therapy to achieve widespread clinical adoption in 2026, larger randomized controlled trials are necessary to verify long-term durability and safety across diverse patient profiles. As independent peer-reviewed data continues to be evaluated, the work of Dr. Gallegos stands as a vital advancement in shifting the focus from lifelong HPV management toward a definitive, non-invasive treatment.
